nach oben

Endocrine Pathology

Erschienen in:

01.09.2008

The Genomic Revolution and Endocrine Pathology

verfasst von: Suzana S. Couto, Robert D. Cardiff

Erschienen in: Endocrine Pathology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

The genome has been sequenced. However, the functions of each gene remain to be elucidated through phenotypic analysis. This analysis has been called phenogenomics. That part of phenogenomics related to disease can be called pathogenomics or Genomic Pathology. The initial phases of disease analysis will use genetically modified mice. The proliferation of ambitious programs designed to use mice for phenogenomics has been met with alarm by comparative pathologists who note the lack of qualified genomic pathologists and of training programs in genomic pathology. While endocrine pathology offers a number of excellent examples of the contributions made by pathologists to the scientific literature, it also contains examples of the hazards of working with untrained, unwary personnel.

Cardiff RD, Rosner A, Hogarth MA, Galvez JJ, Borowsky AD, Gregg JP. Validation: the new challenge for pathology. Toxicol Pathol 32(Suppl 1):31–39, 2004. doi:10.1080/01926230490424662.PubMedCrossRef

Cardiff RD, Ward JM, Barthold SW. ‘One medicine—one pathology’: are veterinary and human pathology prepared? Lab Invest 88:18–26, 2008. doi:10.1038/labinvest.3700695.PubMedCrossRef

Schwabe CW. Cattle, priests, and progress in medicine. Minneapolis: Univ. of Minnesota Press, 1978.

Schwabe CW. Veterinary medicine and human health. Baltimore: Williams and Wilkins, 1984.

Ellwood-Yen K, Graeber TG, Wongvipat J, et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4:223–238, 2003. doi:10.1016/S1535-6108(03)00197-1.PubMedCrossRef

Mahler JF, Stokes W, Mann PC, Takaoka M, Maronpot RR. Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 24:710–716, 1996.PubMed

Nieto AI, Shyamala G, Galvez JJ, Thordarson G, Wakefield LM, Cardiff RD. Persistent mammary hyperplasia in FVB/N mice. Comp Med 53:433–438, 2003.PubMed

Wakefield LM, Thordarson G, Nieto AI, et al. Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med 53:424–432, 2003.PubMed

Kwak EL, Kim S, Zhang J, Cardiff RD, Schmidt EV, Haber DA. Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant. Cancer Res 66:1923–1928, 2006. doi:10.1158/0008-5472.CAN-05-1237.PubMedCrossRef

10.

Borowsky AD, Dingley KH, Ubick E, Turteltaub KW, Cardiff RD, Devere-White R. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia 8:708–715, 2006. doi:10.1593/neo.06373.PubMedCrossRef

11.

Chiaverotti T, Couto SS, Donjacour A, et al. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am J Pathol 172:236–246, 2008. doi:10.2353/ajpath.2008.070602.PubMedCrossRef

12.

Huss WJ, Gray DR, Tavakoli K, et al. Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model. Neoplasia 9:938–950, 2007. doi:10.1593/neo.07562.PubMedCrossRef

13.

Zhou Z, Flesken-Nikitin A, Nikitin AY. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res 67:5683–5690, 2007. doi:10.1158/0008-5472.CAN-07-0768.PubMedCrossRef

14.

Greenberg NM, DeMayo F, Finegold MJ, et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A 92:3439–3443, 1995. doi:10.1073/pnas.92.8.3439.PubMedCrossRef

15.

Kasper S, Sheppard PC, Yan Y, et al. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest 78:319–333, 1998.PubMed

16.

Garabedian EM, Humphrey PA, Gordon JI. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proc Natl Acad Sci U S A 95:15382–15387, 1998. doi:10.1073/pnas.95.26.15382.PubMedCrossRef

17.

Shappell SB, Thomas GV, Roberts RL, et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64:2270–2305, 2004. doi:10.1158/0008-5472.CAN-03-0946.PubMedCrossRef

18.

Ratineau C, Ronco A, Leiter AB. Role of the amino-terminal domain of simian virus 40 early region in inducing tumors in secretin-expressing cells in transgenic mice. Gastroenterology 119:1305–1311, 2000. doi:10.1053/gast.2000.19278.PubMedCrossRef

19.

Syder AJ, Karam SM, Mills JC, et al. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proc Natl Acad Sci U S A 101:4471–4476, 2004. doi:10.1073/pnas.0307983101.PubMedCrossRef

20.

Gum JR Jr., Hicks JW, Crawley SC, et al. Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colon. Mol Cancer Res 2:504–513, 2004.PubMed

21.

Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4:181–189, 2003. doi:10.1016/S1535-6108(03)00220-4.PubMedCrossRef

22.

Linnoila RI, Sahu A, Miki M, Ball DW, DeMayo FJ. Morphometric analysis of CC10-hASH1 transgenic mouse lung: a model for bronchiolization of alveoli and neuroendocrine carcinoma. Exp Lung Res 26:595–615, 2000. doi:10.1080/01902140150216693.PubMedCrossRef

23.

Wikenheiser KA, Clark JC, Linnoila RI, Stahlman MT, Whitsett JA. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res 52:5342–5352, 1992.PubMed

24.

Knostman KA, Jhiang SM, Capen CC. Genetic alterations in thyroid cancer: the role of mouse models. Vet Pathol 44:1–14, 2007. doi:10.1354/vp.44-1-1.PubMedCrossRef

25.

Connolly DC, Bao R, Nikitin AY, et al. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63:1389–1397, 2003.PubMed

26.

Green JE, Shibata MA, Yoshidome K, et al. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19:1020–1027, 2000. doi:10.1038/sj.onc.1203280.PubMedCrossRef

27.

Grippo PJ, Sandgren EP. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. Am J Pathol 157:805–813, 2000.PubMed

28.

Ledent C, Dumont J, Vassart G, Parmentier M. Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice. Endocrinology 129:1391–1401, 1991.PubMedCrossRef

29.

Hu Y, Ippolito JE, Garabedian EM, Humphrey PA, Gordon JI. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice. J Biol Chem 277:44462–44474, 2002. doi:10.1074/jbc.M205784200.PubMedCrossRef

30.

Bosse P, Bernex F, De Sepulveda P, Salaun P, Panthier JJ. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes. Oncogene 14:2661–2670, 1997. doi:10.1038/sj.onc.1201122.PubMedCrossRef

31.

Shen Q, Sun Q, Wei X, et al. Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice model. J Biosci Bioeng 104:14–21, 2007. doi:10.1263/jbb.104.14.PubMedCrossRef

32.

Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. Pten is essential for embryonic development and tumour suppression. Nat Genet 19:348–355, 1998. doi:10.1038/1235.PubMedCrossRef

33.

Podsypanina K, Ellenson LH, Nemes A, et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A 96:1563–1568, 1999. doi:10.1073/pnas.96.4.1563.PubMedCrossRef

34.

Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res 60:3605–3611, 2000.PubMed

35.

Tischler AS, Shih TS, Williams BO, Jacks T. Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene Nf1. Endocr Pathol 6:323–335, 1995. doi:10.1007/BF02738732.PubMedCrossRef

36.

Hawes JJ, Tuskan RG, Reilly KM. Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics 8:121–130, 2007. doi:10.1007/s10048-006-0078-5.PubMedCrossRef

37.

Barthold SW, Borowsky AD, Brayton C, et al. From whence will they come? - A perspective on the acute shortage of pathologists in biomedical research. J Vet Diagn Invest 19:455–456, 2007.PubMed

38.

Cardiff RD. Pathologists needed to cope with mutant mice. Nature 447:528, 2007. doi:10.1038/447528c.PubMedCrossRef

39.

Valli T, Barthold SW, Ward JE, et al. Over 60% of NIH extramural funding involves animal-related research. Vet Pathol 44:962–963, 2007, (author reply 963–964).PubMedCrossRef

Titel: The Genomic Revolution and Endocrine Pathology
verfasst von: Suzana S. Couto
Robert D. Cardiff
Publikationsdatum: 01.09.2008
Verlag: Humana Press Inc
Erschienen in: Endocrine Pathology / Ausgabe 3/2008
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI: https://doi.org/10.1007/s12022-008-9042-2

Springer Medizin

The Genomic Revolution and Endocrine Pathology

Abstract

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

Poorly Differentiated Thyroid Carcinoma: Diagnostic Features and Controversial Issues

Molecular Detection of PPARγ Rearrangements and Thyroid Carcinoma in Preoperative Fine-Needle Aspiration Biopsies

Metastatic Small Cell Carcinoma to the Thyroid Gland: a Pathologic and Molecular Study Demonstrating the Origin in the Urinary Bladder

European Society for Pathology Symposium, September 2007

Expression of p21cip1, p27kip1, and p16INk4a Cyclin-Dependent Kinase Inhibitors in Papillary Thyroid Carcinoma: Correlation with Clinicopathological Factors

Controversies in Thyroid Pathology: The Diagnosis of Follicular Neoplasms

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie